Brain Tumors 2022: From Biology to Therapy
confirmed for 2022
| DAY 1 Wednesday, June 22, 2022 | ||
| 11:00 - 13:00 | Registration and welcome coffee | |
| 13:00 - 14:00 | Keynote lecture: John de Groot, MD Anderson Cancer Center, USA The futute of immunotherapy for glioma |
|
| 14:00 - 17:20 | Brain tumor pathobiology (chairs: Dolores Hambardzumyan, Bozena Kaminska) |
|
| 14:00 - 14:35 | Constantinos G. Hadjipanayis, Mount Sinai Icahn School of Medicine, USA Fluorescence-guided surgery and photodynamic therapy of brain tumors: a new combination |
|
| 14:35 - 15:10 | Martin van den Bent, Erasmus MC Cancer Institute Rotterdam, Netherlands The landscape of clinical trial in glioma: recently completed and ongoing projects |
|
| 15:10 - 15:40 | COFFEE BREAK | |
| 15:40 - 16:15 | Oren Becher, Mount Sinai Icahn School of Medicine, USA Cellular heterogeneity in diffuse midline gliomas |
|
| 16:15 - 16:50 | Jacek Majewski, McGill University, Canada Epigenomic landscapes of H3K27M mutant gliomas |
|
| 16:50 - 17:20 | Oral presentations(3x10 min) | |
| 17:20 - 18:50 | Poster session part I | |
| 19:00 - 21:00 | WELCOME RECEPTION | |
| DAY 2 Thursday, June 23, 2022 | ||
| 09:00 - 12:25 | Glioma microenvironment, immunology and immunotherapy I (chairs: Christel Herold-Mende, Aleksandra Ellert-Miklaszewska) |
|
| 09:00 - 09:35 | Bozena Kaminska, Nencki Institute, Warsaw, Poland Immune microenvironment of glioma at single cell resolution |
|
| 09:35 - 10:10 | Dolores Hambardzumyan, Mount Sinai Icahn School of Medicine, USA Glioblastoma subtype-specific heterogeneity of the immune microenvironment |
|
| 10:10 - 10:40 | COFFEE BREAK | |
| 10:40 - 11:15 | Katrin Lamszus,Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany Cancer immunoediting in malignant glioma - interactions between immune cells and tumor cells |
|
| 11:15 - 11:50 | Dieter Henrik Heiland, University of Freiburg, Germany Spatiotemporal dynamics in the structural immunity of the glioblastoma microenvironment |
|
| 11:50 - 12:25 | Christel Herold-Mende, University of Heidelberg, Germany Determinants of immune cell infiltration and immune responses in brain tumors |
|
| 12:25 - 13:25 | LUNCH BREAK |
|
| 13:25 - 18:00 | Glioma microenvironment, immunology and immunotherapy II (chairs: Dinorah Friedman-Morvinski, Wiesława Grajkowska) |
|
| 13:25 - 14:00 | Alessandro Michelucci, Neuro-Immunology Group, Department of Oncology, Luxembourg Institute of Health, Luxembourg Revealing and harnessing tumour-associated microglia/macrophage heterogeneity in glioblastoma |
|
| 14:00 - 14:35 | Waldemar Debinski, Wake Forest School of Medicine, USA Novel targeted drug candidates for GBM treatment |
|
| 14:35 - 15:10 | Dinorah Friedmann-Morvinski, Tel Aviv University, Israel Boosting CAR-T cell efficacy by modulation of the microenvironment in brain tumors |
|
| 15:10 - 15:35 | COFFEE BREAK | |
| 15:35 - 16:10 | Houtan Noushmehr, Henry Ford Cancer Institute, USA Advances in epigenomic classification and liquid biopsy in glioma |
|
| 16:10 - 16:45 | Neta Erez, Tel Aviv University, Israel Systemic instigation of neuroinflammation facilitates brain metastasis |
|
| 16:45 - 17:20 | Hai-kun Liu, German Cancer Research Center (DKFZ), Germany Metabolic plasticity and cancer stem cell dormancy in glioblastoma |
|
| 17:20 - 17:50 | Oral presentations (3x10 min) | |
| 17:50 - 19:40 | Poster session part II | |
| 20:00 - 23:00 | Gala dinner (by invitation) | |
| DAY 3 Friday, June 24, 2022 | ||
| 09:00 - 16:00 | Brain tumor pathobiology, diagnostics & therapy (chairs: Tika Benveniste, Sergiusz Nawrocki) |
|
| 09:00 - 09:35 | Itay Tirosh, Weizmann Institute of Science, Israel Dissecting intra-tumor and inter-tumor heterogeneity in glioma |
|
| 09:35 - 10:10 | Rolf Bjerkvig, University of Bergen, Norway Glioma cell invasion: growth patterns and mechanistic insight |
|
| 10:10 - 10:40 | COFFEE BREAK | |
| 10:40 - 11:15 | Guido Reifenberger, University of Dusseldorf, Germany Recent advances in the molecular classification of gliomas – The new WHO classification 2021 and beyond |
|
| 11:15 - 11:50 |
|
|
| 11:50 - 12:25 | Svetoslav Kalaydjiev (Perlan) Real-time analysis of cellular function with the Seahorse metabolic analyzer |
|
|
|
LUNCH BREAK |
|
| 13:25 - 14:00 | Maciej Wiznerowicz, International Institute for Molecular Oncology, Poland Cancer Stemness as Hallmark of Oncogenic De-differentiation |
|
| 14:00 - 14:35 | Petra Hamerlik, AstraZeneca, UK Functional interplay between aberrant DNA repair and cellular hierarchies in glioblastoma |
|
| 14:35 - 15:10 | Agnieszka Bronisz, Mossakowski Medical Institute, Poland Targeting hypoxia response for oncolytic virus immunotherapy |
|
| 15:10 - 15:45 | Waldemar Priebe, MD Anderson Cancer Center, University of Texas, Houston, USA Drug discovery in academia: focus on CNS malignancies |
|
| 15:45-16:20 | Glenn Lesser, Wake Forest School of Medicine, USA Trials and Tribulations: Reimagining Our Clinical Trial Approaches to CNS Malignancies |
|
| 16:20 - 16:30 | Closing remarks | |
| 16:30 - 19:00 |
Guided tour: Warsaw sightseeing (optional, free of charge) | |
 |
||